Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy.

PLoS One 2017 6;12(12):e0189051. Epub 2017 Dec 6.

Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, California, United States of America.

Pancreatic ductal adenocarcinoma (PDAC) is characterized by an extremely dense fibrotic stroma, which contributes to tumor growth, metastasis, and drug resistance. During tumorigenesis, quiescent pancreatic stellate cells (PSCs) are activated and become major contributors to fibrosis, by increasing growth factor signaling and extracellular matrix deposition. The p53 tumor suppressor is known to restrict tumor initiation and progression through cell autonomous mechanisms including apoptosis, cell cycle arrest, and senescence. There is growing evidence that stromal p53 also exerts anti-tumor activity by paracrine mechanisms, though a role for stromal p53 in PDAC has not yet been described. Here, we demonstrate that activation of stromal p53 exerts anti-tumor effects in PDAC. We show that primary cancer-associated PSCs (caPSCs) isolated from human PDAC express wild-type p53, which can be activated by the Mdm2 antagonist Nutlin-3a. Our work reveals that p53 acts as a major regulator of PSC activation and as a modulator of PDAC fibrosis. In vitro, p53 activation by Nutlin-3a induces profound transcriptional changes, which reprogram activated PSCs to quiescence. Using immunofluorescence and lipidomics, we have also found that p53 activation induces lipid droplet accumulation in both normal and tumor-associated fibroblasts, revealing a previously undescribed role for p53 in lipid storage. In vivo, treatment of tumor-bearing mice with the clinical form of Nutlin-3a induces stromal p53 activation, reverses caPSCs activation, and decreases fibrosis. All together our work uncovers new functions for stromal p53 in PDAC.

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0189051PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718507PMC
December 2017
15 Reads

Publication Analysis

Top Keywords

stromal p53
20
p53 activation
16
p53
12
p53 exerts
8
stellate cells
8
exerts anti-tumor
8
nutlin-3a induces
8
p53 pdac
8
pancreatic stellate
8
activation
7
pdac
6
stromal
5
p53 activated
4
activated mdm2
4
mdm2 antagonist
4
wild-type p53
4
pdac express
4
isolated human
4
human pdac
4
antagonist nutlin-3a
4

References

(Supplied by CrossRef)
Cancer statistics, 2016
RL Siegel et al.
CA Cancer J Clin 2016
The pancreas cancer microenvironment
C Feig et al.
Clin Cancer Res Off J Am Assoc Cancer Res 2012
Pancreatic cancer: The microenvironment needs attention too!
MV Apte et al.
Pancreatol Off J Int Assoc Pancreatol IAP Al 2015
Pancreatic stellate cells: a starring role in normal and diseased pancreas
MV Apte et al.
Front Physiol 2012
Signal transduction in pancreatic stellate cells
A Masamune et al.
J Gastroenterol 2009

Similar Publications